Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Tojo Toshifumi

Department of Materials, Sichuan University, Chengdu 610064, PR China
Publications

Ensuring Safety and Efficacy: The Importance of Biopharmaceuticals Process Validation

The development and production of biopharmaceuticals represent a pivotal advancement in modern medicine, offering innovative treatments for various diseases, including cancer, autoimmune disorders, and infectious diseases. Biopharmaceuticals, which include therapeutic proteins, monoclonal antibodies, vaccines, and gene therapies, have demonstrated ... Read More»

Tojo Toshifumi

: Clin Pharmacol Biopharm 2023, 12:377

10.4172/2167-065X.1000377

Abstract Peer-reviewed Full Article Peer-reviewed Article PDF Mobile Full Article

Top